Buy Revive Nasal Spray CJC-1295 No DAC + Ipamorelin Blend
Buy Revive Nasal Spray CJC-1295 No DAC + Ipamorelin Blend
Revive Nasal Spray (CJC-1295 No DAC + Ipamorelin Blend)
Revive Nasal Spray offers a convenient and fast-acting method to deliver a powerful peptide blend directly into the bloodstream. By combining CJC-1295 (a growth hormone-releasing hormone analog without drug-affinity component) with Ipamorelin, this formulation aims to maximize endogenous growth hormone secretion while minimizing potential side effects associated with other stimulants. The spray is marketed for research purposes and is available in a ready-to-use powder that can be reconstituted with sterile water or saline.
What is CJC-1295 No DAC?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The "No DAC" variant lacks the drug-affinity component that prolongs its half-life, resulting in a shorter duration of action compared to other GHRH analogues. This allows for more frequent dosing and can reduce accumulation in the body. When administered, CJC-1295 stimulates the pituitary gland to release growth hormone (GH) and subsequently increases insulin-like growth factor-1 (IGF-1) levels, which play a key role in tissue repair, muscle growth, and metabolic regulation.
Mechanism of Action
The combined action of CJC-1295 No DAC and Ipamorelin works through two complementary pathways:
CJC-1295 binds to GHRH receptors on the pituitary somatotrophs, mimicking natural hormone release patterns and prompting GH secretion.
Ipamorelin, a selective ghrelin receptor agonist, enhances GH release by stimulating growth hormone secretagogue receptors (GHS-R1a) while also reducing appetite suppression commonly seen with other peptide stimulants.
Buy Revive Nasal Spray CJC-1295 No DAC + Ipamorelin Blend
Revive Nasal Spray (CJC-1295 No DAC + Ipamorelin Blend)
Revive Nasal Spray offers a convenient and fast-acting method to deliver a powerful peptide blend directly into the bloodstream. By combining CJC-1295 (a growth hormone-releasing hormone analog without drug-affinity component) with Ipamorelin, this formulation aims to maximize endogenous growth hormone secretion while minimizing potential side effects associated with other stimulants. The spray is marketed for research purposes and is available in a ready-to-use powder that can be reconstituted with sterile water or saline.
What is CJC-1295 No DAC?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The "No DAC" variant lacks the drug-affinity component that prolongs its half-life, resulting in a shorter duration of action compared to other GHRH analogues. This allows for more frequent dosing and can reduce accumulation in the body. When administered, CJC-1295 stimulates the pituitary gland to release growth hormone (GH) and subsequently increases insulin-like growth factor-1 (IGF-1) levels, which play a key role in tissue repair, muscle growth, and metabolic regulation.
Mechanism of Action
The combined action of CJC-1295 No DAC and Ipamorelin works through two complementary pathways:
CJC-1295 binds to GHRH receptors on the pituitary somatotrophs, mimicking natural hormone release patterns and prompting GH secretion.
Ipamorelin, a selective ghrelin receptor agonist, enhances GH release by stimulating growth hormone secretagogue receptors (GHS-R1a) while also reducing appetite suppression commonly seen with other peptide stimulants.